The Influence of Referral Source on Characteristics of Patients Undergoing Cardiac Stress Testing: Emergency Department versus Outpatient Office

2011 ◽  
Vol 123 (2) ◽  
pp. 36-41
Author(s):  
Sherry Pinkstaff ◽  
Mary Ann Peberdy ◽  
Michael C. Kontos ◽  
Sheryl Finucane ◽  
Carl J. Lavie ◽  
...  
2019 ◽  
Vol 74 (2) ◽  
pp. 216-223 ◽  
Author(s):  
Shaw Natsui ◽  
Benjamin C. Sun ◽  
Ernest Shen ◽  
Yi-Lin Wu ◽  
Rita F. Redberg ◽  
...  

1998 ◽  
Vol 7 (4) ◽  
pp. 320-327
Author(s):  
LG Futterman ◽  
L Lemberg

The ECG exercise stress test is a very potent aid to the clinical diagnosis of CAD. Thorough knowledge of the ECG abnormalities and clinical features related to the stress test are required for an accurate diagnosis. The ECG exercise stress test is not a substitute for clinical acumen. Proper evaluation of the stress test is a clinical art of the skilled clinician. ECG exercise stress testing can be done efficiently and effectively by trained emergency department physicians. As a result, the diagnosis of CAD can be greatly accelerated.


2015 ◽  
Vol 233 (1) ◽  
pp. 19-37 ◽  
Author(s):  
Swapnil Gupta ◽  
Mohini Ranganathan ◽  
Deepak Cyril D’Souza

Stroke ◽  
2016 ◽  
Vol 47 (suppl_1) ◽  
Author(s):  
Jason J Sico ◽  
Fitsum Baye ◽  
Laura J Myers ◽  
John Concato ◽  
Linda S Williams ◽  
...  

Introduction: Guidelines recommend the use of cardiac stress testing to screen for occult coronary heart disease (CHD) among patients with ischemic stroke/TIA who have a ‘high risk’ Framingham Cardiac Risk score (FCRS). It is unclear whether implementation of this guideline confers a mortality benefit among patients with cerebrovascular disease. Hypothesis: We assessed the hypothesis that cardiac stress testing would be associated with lower odds of one-year all-cause mortality. Methods: Administrative data from a sample of 11,306 Veterans admitted to 134 Veterans Health Administration (VHA) facilities with a stroke or TIA in fiscal year 2011 were analyzed. Patients were excluded (n=6915) on the basis of: prior CHD history, receipt of cardiac stress testing within 18-months prior to cerebrovascular event, death within 90 days of discharge, being discharged to hospice, transferred to a non-VHA acute care facility, or missing/unknown race. A FCRS was calculated for each patient; a score of ≥ 20% was classified as ‘high risk’ of having CHD. Administrative data were used to identify whether cardiac stress testing was performed within 90-days after the cerebrovascular event. Logistic regression was used to assess whether cardiac stress testing was associated with one-year all-cause mortality. Results: Of the 4391 eligible patients, 62.8% (2759) had FCRS ≥ 20%, with 4.5% (n=123) of these patients receiving cardiac stress testing within 90 days of discharge. After adjusting for sociodemographic characteristics and medical comorbidities, FCRS ≥ 20% was associated with one-year mortality (aOR=2.18; CI 95 :1.59, 3.00), however, receipt of stress testing was not (aOR=0.59; CI 95 :0.26, 1.30). Conclusion: Cardiac screening did not confer a one-year all-cause mortality benefit among patients with cerebrovascular disease. Additional work is needed to assess outcomes among patients with cerebrovascular disease who are at ‘high risk’ for CHD.


Sign in / Sign up

Export Citation Format

Share Document